97855 Search Results


95
Novus Biologicals α smooth muscle actin antibody
Routes of fluorescent dextran entry into the brain from CSF. (A) Left: Distribution of 70-kD dextran in brain after low- and high-volume cisternal injections. Center and right: Fluorescence images of the boxed regions at the left, showing the distribution of 2,000-kD FITC dextran, 70-kD TRITC dextran, and 10-kD Alexa Fluor 647 dextran in brain perivascular space and parenchyma. (B) Left: Depth of dye penetration into the perivascular spaces of cortex ( n = 6 mice, * 1 , P = 0.0074; * 2 , P = 0.0165; * 3 , P = 0.0188, repeated-measures two-way ANOVA with Bonferroni posttest). Differences with dextran size not significant. Right: Depth of dye penetration into parenchyma (* 1 , P = 0.0451; n.s. 2 , P > 0.999; n.s. 3 , P > 0.999, repeated-measures two-way ANOVA with Bonferroni posttest). (C) Routes of solute uptake of cisternally injected 70-kD TRITC dextran, counterstained with CD31 (labels all vessels) and <t>α-SMA</t> (labels arterioles). a, descending arteriole; v, ascending venule.
α Smooth Muscle Actin Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α smooth muscle actin antibody/product/Novus Biologicals
Average 95 stars, based on 1 article reviews
α smooth muscle actin antibody - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier

90
Numerical Algorithms Group Inc axiom system
Routes of fluorescent dextran entry into the brain from CSF. (A) Left: Distribution of 70-kD dextran in brain after low- and high-volume cisternal injections. Center and right: Fluorescence images of the boxed regions at the left, showing the distribution of 2,000-kD FITC dextran, 70-kD TRITC dextran, and 10-kD Alexa Fluor 647 dextran in brain perivascular space and parenchyma. (B) Left: Depth of dye penetration into the perivascular spaces of cortex ( n = 6 mice, * 1 , P = 0.0074; * 2 , P = 0.0165; * 3 , P = 0.0188, repeated-measures two-way ANOVA with Bonferroni posttest). Differences with dextran size not significant. Right: Depth of dye penetration into parenchyma (* 1 , P = 0.0451; n.s. 2 , P > 0.999; n.s. 3 , P > 0.999, repeated-measures two-way ANOVA with Bonferroni posttest). (C) Routes of solute uptake of cisternally injected 70-kD TRITC dextran, counterstained with CD31 (labels all vessels) and <t>α-SMA</t> (labels arterioles). a, descending arteriole; v, ascending venule.
Axiom System, supplied by Numerical Algorithms Group Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/axiom system/product/Numerical Algorithms Group Inc
Average 90 stars, based on 1 article reviews
axiom system - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier


N/A
The OCIAD1 Antibody [Alexa Fluor® 750] from Novus is a OCIAD1 antibody to OCIAD1. This antibody reacts with Human. The OCIAD1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The OCIAD1 Antibody [DyLight 350] from Novus is a OCIAD1 antibody to OCIAD1. This antibody reacts with Human. The OCIAD1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
Target species human Gene Silencers generally consist of pools of three to five target specific 19 25 nucleotide sequences in length For independent verification of ZNF85 gene silencing results individual duplex components or plasmids are
  Buy from Supplier



N/A
InformationNitazoxanide (NTZ, NSC 697855) is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent(IC50 for canine influenza virus ranges from 0.17 to 0.21 μM). Nitazoxanide modulatesautophagyand inhibitsmTORC1signaling.In vitroNitazoxanide reduces parasite growth in cell culture by more
  Buy from Supplier

N/A
The OCIAD1 Antibody [Alexa Fluor® 405] from Novus is a OCIAD1 antibody to OCIAD1. This antibody reacts with Human. The OCIAD1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The OCIAD1 Antibody [Alexa Fluor® 594] from Novus is a OCIAD1 antibody to OCIAD1. This antibody reacts with Human. The OCIAD1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
  Buy from Supplier

N/A
The OCIAD1 Antibody [Janelia Fluor® 646] from Novus is a OCIAD1 antibody to OCIAD1. This antibody reacts with Human. The OCIAD1 antibody has been validated for the following applications: Immunohistochemistry-Paraffin.
  Buy from Supplier

Image Search Results


Routes of fluorescent dextran entry into the brain from CSF. (A) Left: Distribution of 70-kD dextran in brain after low- and high-volume cisternal injections. Center and right: Fluorescence images of the boxed regions at the left, showing the distribution of 2,000-kD FITC dextran, 70-kD TRITC dextran, and 10-kD Alexa Fluor 647 dextran in brain perivascular space and parenchyma. (B) Left: Depth of dye penetration into the perivascular spaces of cortex ( n = 6 mice, * 1 , P = 0.0074; * 2 , P = 0.0165; * 3 , P = 0.0188, repeated-measures two-way ANOVA with Bonferroni posttest). Differences with dextran size not significant. Right: Depth of dye penetration into parenchyma (* 1 , P = 0.0451; n.s. 2 , P > 0.999; n.s. 3 , P > 0.999, repeated-measures two-way ANOVA with Bonferroni posttest). (C) Routes of solute uptake of cisternally injected 70-kD TRITC dextran, counterstained with CD31 (labels all vessels) and α-SMA (labels arterioles). a, descending arteriole; v, ascending venule.

Journal: The Journal of General Physiology

Article Title: Application of fluorescent dextrans to the brain surface under constant pressure reveals AQP4-independent solute uptake

doi: 10.1085/jgp.202112898

Figure Lengend Snippet: Routes of fluorescent dextran entry into the brain from CSF. (A) Left: Distribution of 70-kD dextran in brain after low- and high-volume cisternal injections. Center and right: Fluorescence images of the boxed regions at the left, showing the distribution of 2,000-kD FITC dextran, 70-kD TRITC dextran, and 10-kD Alexa Fluor 647 dextran in brain perivascular space and parenchyma. (B) Left: Depth of dye penetration into the perivascular spaces of cortex ( n = 6 mice, * 1 , P = 0.0074; * 2 , P = 0.0165; * 3 , P = 0.0188, repeated-measures two-way ANOVA with Bonferroni posttest). Differences with dextran size not significant. Right: Depth of dye penetration into parenchyma (* 1 , P = 0.0451; n.s. 2 , P > 0.999; n.s. 3 , P > 0.999, repeated-measures two-way ANOVA with Bonferroni posttest). (C) Routes of solute uptake of cisternally injected 70-kD TRITC dextran, counterstained with CD31 (labels all vessels) and α-SMA (labels arterioles). a, descending arteriole; v, ascending venule.

Article Snippet: Antibody sources were as follows: CD31 antibody (550274; BD PharMingen), α smooth muscle actin antibody (NB300-97855; Novus Biologicals), and fluorophore-labeled secondary antibodies (Molecular Probes).

Techniques: Fluorescence, Injection